1N6V
| Average structure of the interferon-binding ectodomain of the human type I interferon receptor | Descriptor: | Interferon-alpha/beta receptor beta chain | Authors: | Chill, J.H, Quadt, S.R, Levy, R, Schreiber, G, Anglister, J. | Deposit date: | 2002-11-12 | Release date: | 2003-07-15 | Last modified: | 2022-02-23 | Method: | SOLUTION NMR | Cite: | The human type I interferon receptor. NMR structure reveals the molecular basis of ligand binding. Structure, 11, 2003
|
|
1N6U
| NMR structure of the interferon-binding ectodomain of the human interferon receptor | Descriptor: | Interferon-alpha/beta receptor beta chain | Authors: | Chill, J.H, Quadt, S.R, Levy, R, Schreiber, G, Anglister, J. | Deposit date: | 2002-11-12 | Release date: | 2003-07-15 | Last modified: | 2022-02-23 | Method: | SOLUTION NMR | Cite: | The human type I interferon receptor. NMR structure reveals the molecular basis of ligand binding. Structure, 11, 2003
|
|
7OD2
| |
7PLL
| Structure of the murine cortactin C-SH3 domain in complex with a Pyk2 proline-rich ligand | Descriptor: | Pyk2-PRR2 peptide, Src substrate cortactin | Authors: | Sokolik, C.G, Samson, A.O, Gil-Henn, H, Chill, J.H. | Deposit date: | 2021-08-31 | Release date: | 2022-07-13 | Last modified: | 2024-06-19 | Method: | SOLUTION NMR | Cite: | A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis. Oncogene, 42, 2023
|
|
2N6B
| |
2HYM
| NMR based Docking Model of the Complex between the Human Type I Interferon Receptor and Human Interferon alpha-2 | Descriptor: | Interferon alpha-2, Soluble IFN alpha/beta receptor | Authors: | Quadt-Akabayov, S.R, Chill, J.H, Levy, R, Kessler, N, Anglister, J. | Deposit date: | 2006-08-07 | Release date: | 2006-10-10 | Last modified: | 2022-03-09 | Method: | SOLUTION NMR | Cite: | Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex Protein Sci., 15, 2006
|
|
6RGN
| BteA131 | Descriptor: | DUF3120 domain-containing protein, SODIUM ION, SULFATE ION | Authors: | Davidov, G, Zarivach, R. | Deposit date: | 2019-04-17 | Release date: | 2019-09-18 | Last modified: | 2024-05-15 | Method: | X-RAY DIFFRACTION (2.01 Å) | Cite: | Structure and membrane-targeting of a Bordetella pertussis effector N-terminal domain. Biochim Biophys Acta Biomembr, 1861, 2019
|
|
5HSP
| MamM CTD M250L | Descriptor: | Magnetosome protein MamM, SULFATE ION | Authors: | Barber-Zucker, S, Zarivach, R. | Deposit date: | 2016-01-26 | Release date: | 2016-11-30 | Last modified: | 2024-01-10 | Method: | X-RAY DIFFRACTION (1.79 Å) | Cite: | Disease-Homologous Mutation in the Cation Diffusion Facilitator Protein MamM Causes Single-Domain Structural Loss and Signifies Its Importance. Sci Rep, 6, 2016
|
|
1LJZ
| NMR structure of an AChR-peptide (Torpedo Californica, alpha-subunit residues 182-202) in complex with alpha-Bungarotoxin | Descriptor: | Acetylcholine receptor protein, alpha-Bungarotoxin | Authors: | Samson, A.O, Scherf, T, Eisenstein, M, Chill, J.H, Anglister, J. | Deposit date: | 2002-04-23 | Release date: | 2002-07-17 | Last modified: | 2013-07-24 | Method: | SOLUTION NMR | Cite: | The mechanism for acetylcholine receptor inhibition by alpha-neurotoxins and species-specific resistance to alpha-bungarotoxin revealed by NMR. Neuron, 35, 2002
|
|